Male Men1 heterozygous mice exhibit fasting hyperglycemia in the early stage of MEN1.
暂无分享,去创建一个
Qingzhong Hu | G. Jin | Yuli Guo | Houjian Zhang | Xiaorui Bao | Siqi Wang | Zhongxiuzi Gao | Li Zhang | Wenting Xie | Yi Chen | Zeen Wang | Maoqiang Xue
[1] C. Deng,et al. Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion , 2014, Proceedings of the National Academy of Sciences.
[2] S. Kahn,et al. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future , 2014, The Lancet.
[3] Weiqing Wang,et al. Hepatic menin recruits SIRT1 to control liver steatosis through histone deacetylation. , 2013, Journal of hepatology.
[4] Z. Yin,et al. Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription , 2013, Proceedings of the National Academy of Sciences.
[5] J. Bilezikian,et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). , 2012, The Journal of clinical endocrinology and metabolism.
[6] L. Wuescher,et al. Menin liver-specific hemizygous mice challenged with high fat diet show increased weight gain and markers of metabolic impairment , 2012, Nutrition & Diabetes.
[7] K. Dreijerink,et al. Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers , 2012, Clinical endocrinology.
[8] Xian-gui Hu,et al. Menin prevents liver steatosis through co‐activation of peroxisome proliferator‐activated receptor alpha , 2011, FEBS letters.
[9] L. Wuescher,et al. Insulin regulates menin expression, cytoplasmic localization, and interaction with FOXO1. , 2011, American journal of physiology. Endocrinology and metabolism.
[10] D. Edgerton,et al. Physiologic action of glucagon on liver glucose metabolism , 2011, Diabetes, obesity & metabolism.
[11] Beppie van den Bogaerde,et al. Clinical practice , 2011, European Journal of Pediatrics.
[12] X. Hua,et al. Deletion of the Men1 Gene Prevents Streptozotocin-Induced Hyperglycemia in Mice , 2011, Experimental diabetes research.
[13] X. Hua,et al. Reversal of preexisting hyperglycemia in diabetic mice by acute deletion of the Men1 gene , 2010, Proceedings of the National Academy of Sciences.
[14] S. Libutti,et al. Multiple endocrine neoplasia type 1 deletion in pancreatic alpha-cells leads to development of insulinomas in mice. , 2010, Endocrinology.
[15] Aidan S. Hancock,et al. Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice. , 2010, Molecular endocrinology.
[16] P. Herrera,et al. Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development. , 2010, Gastroenterology.
[17] Jeffrey A. Bluestone,et al. Genetics, pathogenesis and clinical interventions in type 1 diabetes , 2010, Nature.
[18] P. Roach,et al. Molecular Characterization of Insulin-Mediated Suppression of Hepatic Glucose Production In Vivo , 2010, Diabetes.
[19] R. Scharfmann,et al. Tumour suppressor menin is essential for development of the pancreatic endocrine cells. , 2008, The Journal of endocrinology.
[20] Xueying Gu,et al. Menin Controls Growth of Pancreatic ß-Cells in Pregnant Mice and Promotes Gestational Diabetes Mellitus , 2007, Science.
[21] J. Wahren,et al. Splanchnic regulation of glucose production. , 2007, Annual review of nutrition.
[22] W. Knoefel,et al. Multiple endocrine neoplasia type 1 (MEN1): loss of one MEN1 allele in tumors and monohormonal endocrine cell clusters but not in islet hyperplasia of the pancreas. , 2007, The Journal of clinical endocrinology and metabolism.
[23] G. Kay,et al. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1 , 2007, International journal of cancer.
[24] M. Drent,et al. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review , 2007, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[25] S. Kahn,et al. Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.
[26] R. Mccallum,et al. Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose , 2006, Clinical endocrinology.
[27] X. Hua,et al. Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells. , 2006, Cancer research.
[28] W. Knoefel,et al. Microadenomatosis of the Endocrine Pancreas in Patients With and Without the Multiple Endocrine Neoplasia Type 1 Syndrome , 2006, The American journal of surgical pathology.
[29] Melanie Scott,et al. Insulin's direct effects on the liver dominate the control of hepatic glucose production. , 2006, The Journal of clinical investigation.
[30] A. de Leiva,et al. Patients with MEN-1 are more insulin-resistant than their non-affected relatives. , 2005, European journal of internal medicine.
[31] O. Rozenblatt-Rosen,et al. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] S. Marx. Molecular genetics of multiple endocrine neoplasia types 1 and 2 , 2005, Nature Reviews Cancer.
[33] Alvin C. Powers,et al. Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal Microscopy , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[34] S. Marx. Molecular genetics of multiple endocrine neoplasia types 1 and 2 , 2005, Nature Reviews Cancer.
[35] Michael Roden,et al. Hepatic glucose metabolism in humans--its role in health and disease. , 2003, Best practice & research. Clinical endocrinology & metabolism.
[36] Zhao-Qi Wang,et al. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. , 2003, Molecular endocrinology.
[37] Ralph A. DeFronzo,et al. Metabolic and molecular basis of insulin resistance , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[38] F. Collins,et al. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[39] F. Collins,et al. Isolation, genomic organization, and expression analysis of Men1, the murine homolog of the MEN1 gene , 1999, Mammalian Genome.
[40] J. Bilezikian,et al. Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 ( MEN 1 ) , 2012 .
[41] P. Boyle,et al. Pathophysiology and Treatment , 2000 .